Heterologous immunization with improved HIV1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challenge

dc.article.end-page21en
dc.article.start-page1en
dc.citation.doi10.3390/V17020277en
dc.contributor.authorG Chegeen
dc.contributor.authorR Chapmanen
dc.contributor.authorA Keyseren
dc.contributor.authorC Adamsen
dc.contributor.authorBronwen Lambsonen
dc.contributor.authorTandile Hermanusen
dc.contributor.authorPenelope Mooreen
dc.contributor.author" "et al"en
dc.date.accessioned2025-09-02T13:11:29Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1999-4915en
dc.identifier.urihttps://hdl.handle.net/10539/46194
dc.journal.titleHeterologous immunization with improved HIV1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challengeen
dc.journal.volume17en
dc.titleHeterologous immunization with improved HIV1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challengeen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.3 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client